INOVIO to Participate in Upcoming Scientific Conference

PLYMOUTH MEETING, Pa., April 1, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that it will participate in the following scientific conference: World Federation of Hemophilia World Congress (Kuala Lumpur) Presentation: Next Gen Protein Replacement Therapeutics: DNA-Encoded Protein (DPROT) Technology Demonstrates in vivo Production of Functional FVIII in Mouse Model Date: Wednesday, April 22 Time: 9:45 AM MYT Poster Presentation: FVIII Expression Via Non-viral Vector DNA Medicine Platform Results in Efficacious Levels of FVIII Protein and Correction of the Bleeding Phenotype in Hemophilia A Mice Date: Wednesday, April 22 Time: 10:45 AM MYT Available abstracts will be shared on INOVIO's website following presentations.